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Current T cell differentiation models invoke separate
T helper 2 (Th2) and Th1 cell lineages governed by the
lineage-specifying transcription factors GATA-3 and
T-bet. However, knowledge on the plasticity of Th2
cell lineage commitment is limited. Here we show
that infection with Th1 cell-promoting lymphocytic
choriomeningitis virus (LCMV) reprogrammed other-
wise stably committed GATA-3+ Th2 cells to adopt
a GATA-3+T-bet+ and interleukin-4+interferon-g+
‘‘Th2+1’’ phenotype that was maintained in vivo for
months. Th2 cell reprogramming required T cell
receptor stimulation, concerted type I and type II
interferon and interleukin-12 signals, and T-bet.
LCMV-triggered T-bet induction in adoptively trans-
ferred virus-specific Th2 cells was crucial to prevent
viral persistence and fatal immunopathology. Thus,
functional reprogramming of unfavorably differenti-
ated Th2 cells may facilitate the establishment of
protective immune responses. Stable coexpression
of GATA-3 and T-bet provides a molecular concept
for the long-term coexistence of Th2 and Th1 cell
lineage characteristics in single memory T cells.
INTRODUCTION
Depending on polarizing cytokine signals during activation by
antigen, naive CD4+ T cells can initiate various differentiation
programs that lead to the development of distinct functional line-
ages. The developmental programs are each characterized by
the enhanced production of a key transcription factor that acts
as a lineage-specifying ‘‘master regulator’’ coordinating the
accessibility and expression of defined subsets of cytokine
genes and other genes (Glimcher and Murphy, 2000; Mosmann
and Coffman, 1989; Murphy and Reiner, 2002; Wilson et al.,116 Immunity 32, 116–128, January 29, 2010 ª2010 Elsevier Inc.2009). The transcription factor T-box-containing protein ex-
pressed in T cells (T-bet) is the master regulator of the T helper
1 (Th1) differentiation program associated with the production
of interferon-g (IFN-g) required for efficient immune responses
against intracellular pathogens (Szabo et al., 2000). GATA-
binding protein 3 (GATA-3) controls the development of the
Th2 cell lineage that is characterized by the secretion of inter-
leukin-4 (IL-4), IL-5, and IL-13 critical for immunity against
helminths and other extracellular pathogens (Zhang et al.,
1997; Zheng and Flavell, 1997). However, differentiated Th cells
along with their cytokines can also contribute to undesired,
disadvantageous immune responses (Mosmann and Coffman,
1989; Murphy and Reiner, 2002; Wilson et al., 2009). Particularly
in allergy and asthma, the persistence of Th2 cells and Th2 cyto-
kine production is associated with exacerbation of disease.
Therefore, reprogramming of Th2 cell lineage commitment is
a key target of allergen-specific immunotherapy, which aims at
altering the Th2-Th1 cell balance (Hawrylowicz and O’Garra,
2005; Holgate and Polosa, 2008).
Current models of Th1 and Th2 cell differentiation have postu-
lated mutually exclusive expression patterns of the master
regulators T-bet and GATA-3, respectively (Lo¨hning et al.,
2002; Mariani et al., 2004; Murphy and Reiner, 2002; Zhou
et al., 2009). This notion, largely based on analyses performed
in vitro, is supported by the observation of cytokine-mediated
reinforcement and reciprocal inhibition of both differentiation
programs. For example, Th2 cells lose sensitivity to the Th1
cell-inducing cytokine IL-12 via downregulation of IL-12 receptor
b2 (IL-12Rb2) and signal transducer and activator of transcrip-
tion 4 (STAT4) expression (Szabo et al., 1997; Usui et al.,
2003). In Th1 cells, T-bet and Runx3 cooperate to repress
expression of the Th2 cell-inducing cytokine IL-4 (Djuretic
et al., 2007; Naoe et al., 2007). These differential characteristics
of Th1 and Th2 cells are likely to contribute to the stability of the
respective differentiation lineages (Glimcher and Murphy, 2000;
Lo¨hning et al., 2002; Mariani et al., 2004; Murphy and Reiner,
2002; Wilson et al., 2009; Zhou et al., 2009).
Indeed, several reports found especially Th2 cells to be rather
stably committed and resistant to reprogramming toward Th1
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Interferons Direct Th2 Cell Reprogramming by T-betcells in vitro (Hu-Li et al., 1997; Messi et al., 2003; Murphy et al.,
1996; Perez et al., 1995; Szabo et al., 1995). To challenge the
commitment of virus-specific Th2 cells and to investigate its
functional consequences in vivo, we have employed an infection
model with lymphocytic choriomeningitis virus (LCMV) known for
its strong induction of type I and type II interferons and its potent
Th1 cell-favoring effects (Lo¨hning et al., 2008; Mu¨ller et al., 1994;
Varga and Welsh, 2000). We found that LCMV infection in vivo as
well as a combination of type I and type II interferons plus inter-
leukin-12 in vitro reprogrammed otherwise stably committed
GATA-3+ Th2 cells to adopt a GATA-3+T-bet+ ‘‘Th2+1’’ pheno-
type with the capacity to coproduce Th2 and Th1 cytokines
upon reactivation. Functional relevance of the reprogramming
process was evident from the observation that the LCMV-trig-
gered induction of T-bet in adoptively transferred virus-specific
Th2 cells was essential to mount a protective antiviral response,
preventing uncontrolled viremia and lethality. Remarkably, the
intermediate GATA-3+T-bet+ Th2+1 phenotype was stably main-
tained in vivo for months, suggesting ‘‘lineage-like’’ properties.
Our findings thus reveal a molecular concept for the long-term
balanced coexistence of Th2 and Th1 cell lineage characteristics
in single memory T cells and highlight its functional potential
in a viral infection in vivo.
RESULTS
Th2 Cells Resist Reprogramming toward Th1 Cells
by IL-12 and IFN-g
To study the plasticity of the Th2 cell lineage, naive LCMV-
specific CD4+ T cells (Oxenius et al., 1998) were differentiated
to Th2 cells and challenged under Th1 cell-polarizing conditions
in vitro. Already after 5 days of differentiation, Th2 cells were
resistant to reprogramming toward Th1 cells by IL-12 with or
without IFN-g (Figure S1A available online). In response to these
stimuli, the cells continued to produce Th2 cytokines and re-
mained negative for IFN-g, which is in line with previous reports
(Hu-Li et al., 1997; Messi et al., 2003; Murphy et al., 1996; Perez
et al., 1995; Szabo et al., 1995). At the same time, IL-12 induced
strong Th1 cell differentiation and IFN-g production in naive
CD4+ T cells (Figure S1B). Next, we analyzed the expression of
GATA-3 and T-bet proteins by FACS. Virtually all cells of the
Th2 cell population produced GATA-3 but not T-bet, demon-
strating their homogeneous Th2 cell differentiation (Figure S1C).
Secondary stimulation in the presence of IL-12 with or without
IFN-g led to only minor reductions in the amount of GATA-3
protein, and T-bet expression remained very low when com-
pared with the amounts observed in Th1 cells (Figures S1C
and S1D). Thus, the stability of GATA-3 and lack of T-bet expres-
sion matched the stability of Th2 cytokine production and failure
of Th1 cytokine induction in Th2 cells even under Th1 cell-polar-
izing conditions.
Th2 and Th1 Memory Cells Maintain Preferential
Production of Key Transcription Factors and Cytokines
To address the long-term stability of key transcription factor
production and other functional features of Th cell differentiation
programs, LCMV-specific Thy1.1+ Th2 and Th1 cells were
adoptively transferred into normal, nonlymphopenic C57BL/6
mice. The fate of the transferred Thy1.1+CD4+ cells in theThy1.2+ recipient mice was tracked over time. After adoptive
transfer, protein expression of GATA-3 in Th2 cells and T-bet
in Th1 cells remained stable for >70 days (Figure 1A). Throughout
time, Th2 cells maintained significantly higher GATA-3 protein
expression than did Th1 cells, while Th1 cells maintained higher
T-bet protein expression than did Th2 cells. Notably, Th2 and
Th1 cells continued to produce their lineage-specifying tran-
scription factors in a homogeneous manner over time, such
that virtually all cells of the population remained positive for
GATA-3 or T-bet, respectively, at all time points analyzed (Fig-
ure 1B). In line with the stable maintenance of differential key
transcription factor expression, also the differential pattern of
Th2 or Th1 cytokine production was stably maintained (Fig-
ure 1C; Figure S2). One month after transfer, Th2 cells continued
to produce Th2, but not Th1, cytokines after reactivation, while
Th1 cells secreted Th1, but not Th2, cytokines. Thus, in the
absence of challenge with viral antigen, resting Th2 and Th1
memory cells stably maintained their respective differentiation
programs, as determined by differential production of key
transcription factors and cytokines over time.
Virus Infections Reveal Plasticity of Th2 Cells
in the Context of Specific TCR Stimulation
To challenge the stability of Th2 memory cells in vivo, naive
LCMV-specific CD4+ T cells were differentiated to Th2 or Th1
cells for 3 weeks with weekly reactivations. Then they were
adoptively transferred into normal C57BL/6 mice that were
infected with LCMV 30 days later. Already 7 days after infection,
>80% of the Th2 cells had acquired the capacity to produce
IFN-g (Figure 2A). This result implies considerable plasticity of
Th2 memory cells in vivo, which strongly contrasts with the
previous finding of Th2 cell stability against attempted reprog-
ramming in vitro with IL-12 and IFN-g (compare Figures S1A
and S1C). At the same time, >30% of the former Th2 cells main-
tained the production of IL-4 and IL-13. Remarkably, virtually all
IL-4+ and IL-13+ cells coproduced IFN-g, indicating a simulta-
neous stability of memory for Th2 cytokine production in
conjunction with plasticity to acquire additional Th1 cytokine
secretion (Figure 2A and data not shown).
The infection of Th2 cell recipients with an LCMV variant
lacking the specific CD4+ T cell epitope in its glycoprotein
(LCMV-WEDGP61-68) (Recher et al., 2004) failed to induce IFN-g
production in LCMV-specific Th2 cells, despite its ability to
partially reduce the Th2 cells’ capacity to secrete IL-4 (Figure 2B).
Thus, the cytokine milieu elicited by an LCMV infection as such
was insufficient to mediate the reprogramming of Th2 memory
cells toward additional IFN-g production. Instead, this process
required concomitant stimulation via the T cell receptor (TCR).
Taken together, these results demonstrated the plasticity of
Th2 cell lineage commitment upon TCR triggering in the context
of an LCMV infection.
Virus-Driven Th2 Cell Reprogramming Requires
Induction of T-bet
To elucidate the molecular processes associated with LCMV-
induced Th2 cell reprogramming, the protein expression of key
transcription factors was analyzed. Before infection, LCMV-
specific Th2 memory cells maintained high GATA-3 and very
low T-bet amounts (Figure 3A). Th1 memory cells, in turn,Immunity 32, 116–128, January 29, 2010 ª2010 Elsevier Inc. 117
Day 29 after transfer, uninfected
10
0
10
1
10
2
10
3
10
4
10
0
101
102
103
10
4
0.17 0.1
59.2
10
0
101
102
103
10
4
44.9 0.41
1.44
IFN-g
IL
-4
0
10
1
10
2
10
3
10
4
0.13 0
0.03
0 0
0.06
Isotype
Is
ot
yp
e
1010
0
10
1
10
2
10
3
10
4
0.04 57.3
38.14.57
0 1.93
9
0
.9
7.14
TNF-a
IF
N
-g
10
0
10
1
10
2
10
3
10
4
0.11 0.06
16.6
0.44 0.49
12.6
IL
-1
7
IL-2
10
0
10
1
10
2
10
3
10
4
0.26 0
0.16
21 1.7
0.23
IL-5
IL
-1
3
10
0
10
1
10
2
10
3
10
4
0.34 0.03
0.46
29.5 14.6
4.46
IL
-4
IL-10
Th2
Th1
C
B
10
0
10
1
10
2
10
3
10
4
0
20
40
60
80
100
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
0
20
40
60
80
100
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
GATA-3
T-bet
Ce
ll n
u
m
be
rs
Ce
ll n
u
m
be
rs
Th2
Th1
Day 6 Day 13 Day 33 Day 73
Stain
Isotype
A
Time after transfer (days)
G
AT
A-
3
(G
eo
 m
ea
n i
nd
ex
) Th1
Th2GATA-3
T-
be
t 
(G
eo
 m
ea
n i
nd
ex
) T-bet Th1
Th2
3 13 23 33 43 53 63 73
0
5
10
15
20
3 13 23 33 43 53 63 73
0
5
10
15
20
*
*
* *
*
*
Figure 1. Th2 and Th1 Memory Cells Maintain Preferential Production of Key Transcription Factors and Cytokines
Naive LCMV-specific CD4+Thy1.1+ cells were differentiated to Th2 or Th1 cells for 2 weeks with weekly reactivations. Then Th2 or Th1 cells were transferred into
naive untreated C57BL/6 mice.
(A and B) At the indicated time points after transfer, GATA-3 and T-bet protein expression was determined in peripheral blood of Th2 or Th1 cell recipients by
FACS. (A) The geometric mean index depicts the factor of change of GATA-3 or T-bet staining in CD4+Thy1.1+ donor cells compared with the GATA-3 or
T-bet values in endogenous naive CD62LhiCD4+Thy1.2+ T cells. Data represent the mean ± SD of n = 4–8 mice per group and time point. ***p < 0.001 at all
measured time points.
(C) 29 days after cell transfer, cytokine production of CD4+Thy1.1+ donor cells was measured upon restimulation of splenocytes with antigenic GP64-80 peptide.
Percentages of cytokine+ cells within CD4+Thy1.1+ donor cells are indicated. Data are representative of at least two independent experiments.
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Interferons Direct Th2 Cell Reprogramming by T-betshowed reciprocal key transcription factor production, and this
was not altered by LCMV infection. In Th2 cells, however,
LCMV infection induced substantial production of T-bet, reach-
ing the amount found in Th1 cells, while enhanced GATA-3
production was maintained, albeit to a reduced degree. Remark-
ably, in the course of the viral infection, former Th2 cells
homogeneously adopted a GATA-3+T-bet+ phenotype reminis-
cent of their sequential Th2 and Th1 cell differentiation history
(Figure 3B). The pattern of T-bet production correlated with the118 Immunity 32, 116–128, January 29, 2010 ª2010 Elsevier Inc.capacity to coproduce IFN-g. Before infection, only Th1, but
not Th2, memory cells contained enhanced amounts of T-bet
and produced IFN-g upon reactivation (Figure 3C). At day 9 after
infection, however, the progeny of the former Th2 cells exhibited
similar frequencies of T-bet+IFN-g+ cells as it was observed in
the Th1 cell population. Notably, production of IFN-g was posi-
tively correlated with high amounts of T-bet protein, and this
was the case for the progeny of both former Th2 and Th1
memory cells (Figures 3C and 3D). Th2 cells gave rise to a
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Figure 2. Virus Infections Reveal Plasticity of Th2 Cells in the Context of Specific TCR Stimulation
Naive LCMV-specific CD4+Thy1.1+ cells were differentiated to Th2 or Th1 cells for 3 weeks with weekly reactivations before transfer into naive untreated
C57BL/6 mice. 30 days after transfer, Th2 and Th1 cell recipients were infected with wild-type (WT) LCMV-WE or an LCMV-WE variant, LCMV-WEDGP61-68,
with partial deletion of the antigenic CD4+ T cell epitope.
(A) 7 days after infection with WT LCMV-WE, cytokine production of CD4+Thy1.1+ donor cells was measured upon restimulation of lymph node cells with PMA
plus ionomycin (n = 2 mice per group). Data are representative of at least five independent experiments.
(B) Mean frequencies ± SEM of cytokine+ cells within CD4+Thy1.1+ donor cells in spleen and lymph nodes of Th2 cell recipients before infection and 7 days after
infection with LCMV-WEDGP61-68 or WT LCMV-WE are indicated. ns, not significant; *p < 0.05; **p < 0.01; ***p < 0.001.
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Interferons Direct Th2 Cell Reprogramming by T-betsimilarly high fraction of IFN-g producers as did Th1 cells.
However, the amount of IFN-g expressed in the former was
reduced to about half the amount found in the latter, possibly
because of an inhibitory effect of GATA-3 (Figure 3D).
To address whether T-bet protein, which is encoded by the
Tbx21 gene, was required for Th2 cell reprogramming, we adop-
tively transferred LCMV-specific Th2 cells of wild-type (WT),
Tbx21+/, and Tbx21/ genotypes into Thy1.1 congenic
C57BL/6 mice and infected the recipients with LCMV. The
progeny of the LCMV-specific Th2 cells of all genotypes main-
tained a similar capacity to produce IL-4 (Figure 3E). However,
Tbx21/ Th2 cells could not be induced to produce IFN-g at
all, such that the frequency of IFN-g+ cells in WT or Tbx21+/
Th2 cells exceeded the frequency in Tbx21/ Th2 cells by
a factor >100. This finding indicated an essential role for T-bet
in LCMV-induced Th2 cell reprogramming.
Long-Term Maintenance of the Virus-Induced
GATA-3+T-bet+ and IL-4+IFN-g+ Th2+1 Phenotype In Vivo
To investigate the long-term stability of the LCMV-induced
GATA-3+T-bet+ and IL-4+IFN-g+ Th2+1 phenotype, we infected
mice that had received LCMV-specific Th2 or Th1 cells with
LCMV. Protein expression of the key transcription factors was
quantified in the transferred cells during the subsequent60 days. GATA-3 expression in Th2 cells was reduced to about
half within 6–7 days after infection. Thereafter, it remained
constant at this intermediate expression for the remaining obser-
vation period (Figure 4A). Simultaneously, T-bet expression
increased within the first days after infection. By day 9, T-bet
proteins reached a plateau that was established slightly below
the high T-bet amount of Th1 memory cells and that was stably
maintained at least until day 60. During 2 months after infection,
Th1 cells largely retained the high T-bet and low GATA-3 expres-
sion that was present already before infection. Of note, the
intermediate GATA-3 expression of former Th2 cells was still
significantly (p < 0.01) higher than the constantly low GATA-3
expression found in Th1 cells. Importantly, even 30 and
60 days after LCMV infection (i.e., long after the resolution of
the infection, which usually occurs within a week), the progeny
of the former Th2 cells stably retained a homogeneous GATA-3
and T-bet coproducing phenotype at the single-cell level
(Figure 4A, insert). Likewise, also the mixed pattern of Th2 and
Th1 cytokine (co)production, most prominently the IL-4+IFN-g+
phenotype, was stably maintained in the memory phase
60 days after LCMV infection (Figure 4B, compare Figure 2A).
In summary, these results showed the long-term stability of the
GATA-3+T-bet+ Th2+1 cell differentiation in vivo and suggested
lineage-like properties of Th2+1 cells.Immunity 32, 116–128, January 29, 2010 ª2010 Elsevier Inc. 119
A B
C
IFN-g
T-
be
t
IFN-g
G
AT
A-
3
Day 9 after LCMV infection
Stain
Isotype
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
IFN-g
T-
be
t
Uninfected
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
Th1
Th2
Th2
Th1
2
4
6
8
10
12
2
4
6
8
10
12
2
4
6
8
10
2
3
4
5
G
AT
A-
3
(G
eo
 m
ea
n i
nd
ex
)
T-
be
t
(G
eo
 m
ea
n i
nd
ex
)
Th2 Th1 Th2 Th1
Uninfected
Day 9 
after infection
GATA-3
T-
be
t
Day 9 
after infection
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
10
0
10
1
10
2
10
3
10
4
Stain
Isotype
0
250
500
750
1000
1250
1500
WT Th2
Tbx21-/- Th2
Tbx21+/- Th2
IFN-g
IL-4
Cy
to
kin
e+
 
o
f C
D4
+
 
Th
y1
.2
+
 
ce
lls
 (%
)
2
3
4
5
2
3
4
5
2
4
6
8
10
12
2
4
6
8
10
12
Day 9 
after infection
IFN-g+ IFN-g-
G
AT
A-
3
(G
eo
 m
ea
n i
nd
ex
)
T-
be
t
(G
eo
 m
ea
n i
nd
ex
)
IF
N
-g
 
(G
eo
 m
ea
n)
Th2 Th1 Th2 Th1
Th2 Th1
D E
Th1
Th2
0
10
20
30
40
50
60
0
10
20
30
40
50
60
70
80
IFN-g+
0.45 % 
+/- 
0.17
**
ns
* ***
*** *
ns ns
**
*
ns
***
***
ns
ns ns
0.39
75.4
77.5
74.5
77.5
74.5
Figure 3. Virus-Driven Th2 Cell Reprogram-
ming Requires Induction of T-bet
(A–D) Naive LCMV-specific CD4+Thy1.1+ cells
were differentiated to Th2 or Th1 cells for 2 weeks
before transfer into naive C57BL/6 mice. 14 days
later, Th2 and Th1 cell recipients were infected
with LCMV-WE or were left untreated. T-bet,
GATA-3, and IFN-g protein expression of
CD4+Thy1.1+ donor cells was determined upon re-
stimulation of splenocytes with GP64-80 peptide at
day 23 after transfer and day 9 after infection.
(A) Geometric mean indices ± SEM of T-bet or
GATA-3 stainings versus isotype control stainings
are depicted (n= 2–3 mice per group and time point).
(B and C) Dot plot overlays illustrate T-bet and
GATA-3 coproduction (B) and IFN-g coproduction
with T-bet or GATA-3 before and after LCMV
infection (C).
(D) Geometric mean indices ± SEM of T-bet and
GATA-3 stainings within gated IFN-g+ and IFN-g–
CD4+Thy1.1+ donor cells (left) and geometric
means ± SEM of IFN-g stainings in gated IFN-g+
CD4+Thy1.1+ donor cells (right) were determined.
(E) Naive WT, Tbx21+/, and Tbx21/ LCMV-
specific CD4+Thy1.2+ cells were differentiated to
Th2 cells for 2 weeks, followed by transfer into
naive Thy1.1 congenic mice. 15 days after trans-
fer, recipients were infected with LCMV-WE. 7
days later, cytokine production of CD4+Thy1.2+
donor cells was measured upon restimulation of
splenocytes with PMA plus ionomycin. Mean
frequencies ± SEM of cytokine+ cells within
CD4+Thy1.2+ donor cells are indicated (n = 3
mice per group).
Data are representative of two independent exper-
iments. ns, not significant; *p < 0.05; **p < 0.01;
***p < 0.001.
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Interferons Direct Th2 Cell Reprogramming by T-betType I and Type II Interferons and IL-12 Are Essential
for Virus-Induced Th2 Cell Reprogramming
To investigate LCMV-induced cytokine signals that could be
responsible for the observed Th2 cell reprogramming, we
considered that STAT4 and STAT1 signals are implicated in the
induction of T-bet in developing Th1 cells (Afkarian et al., 2002;
Mullen et al., 2001; Szabo et al., 2000). Indeed, markedly
increased serum concentrations of IFN-a, IL-12, and IFN-g,
which are potent activators of STAT4 and STAT1, were detected
within 4–72 hr after LCMV infection (Figure S3). Next, we120 Immunity 32, 116–128, January 29, 2010 ª2010 Elsevier Inc.analyzed the phosphorylation of STAT4
and STAT1 in response to these cytokine
stimuli in Th2 and Th1 cells rested in vivo
for 15 days (Figure 5A). IL-12 induced
strong STAT4 and weaker STAT1 phos-
phorylation in Th1, but not Th2, cells,
which is in agreement with previous
descriptions of the loss of IL-12Rb2 chain
expression selectively in Th2 cells
(Ouyang et al., 1998; Szabo et al., 1995,
1997). IFN-g, instead, mediated STAT1
phosphorylation exclusively in Th2 cells,
which may relate to a reported downregu-
lation of IFN-gR2 expression in Th1 cells(Pernis et al., 1995). Notably, type I interferons retained the
capacity to induce phosphorylation of both STAT4 and STAT1
in Th2 and Th1 cells. Moreover, a combination of type I and
type II interferons exhibited additive effects on STAT1 phosphor-
ylation in Th2 cells. Thus, type I and type II interferons, but
not IL-12, could induce STAT4 and STAT1 activation in resting
Th2 cells. However, as previously reported (Usui et al., 2003),
resting Th2 cells contained clearly reduced total STAT4 protein
amounts when compared with their Th1 cell counterparts
(Figure 5B). Within 2 weeks after LCMV infection, the cytokine
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Figure 4. Long-Term Maintenance of the Virus-Induced GATA-3+T-bet+ and IL-4+IFN-g+ Th2+1 Phenotype In Vivo
Naive LCMV-specific CD4+Thy1.1+ cells were differentiated to Th2 or Th1 cells for 2 weeks before transfer into naive untreated C57BL/6 mice. 14–30 days later,
recipients were infected with LCMV-WE.
(A) At the indicated time points, T-bet and GATA-3 protein expression was determined in peripheral blood by FACS (n = 3–5 mice per group and time point).
Geometric mean indices ± SEM of GATA-3 or T-bet staining intensity in CD4+Thy1.1+ donor cells versus endogenous naive CD62LhiCD4+Thy1.2+ T cells is
depicted.
(A, insert) T-bet and GATA-3 coexpression of former Th2 cells on day 30 after infection is shown. The difference in GATA-3 expression between Th2 and Th1 cells
was highly significant throughout time (p < 0.01) with the exception of day 6 after infection. The difference in T-bet expression between Th2 and Th1 cells was
significant at day 0, day 9, and day 30 (p < 0.05).
(B) 60 days after infection, cytokine production of CD4+Thy1.1+ donor cells was measured upon restimulation of splenocytes with PMA plus ionomycin
(n = 2 mice). Data are representative of two independent experiments.
Immunity
Interferons Direct Th2 Cell Reprogramming by T-betresponsiveness of virus-specific Th2 cells underwent consider-
able changes. The cells had gained IL-12 responsiveness and
lost IFN-g responsiveness, as determined by IL-12-induced
STAT4 phosphorylation and the lack of IFN-g-induced STAT1
activation (Figure 5B; Figure S4). In addition, total STAT4 protein
amounts now were comparably high in Th1 and former Th2 cells
(Figure 5B). Taken together, in the course of the LCMV infection,
the cytokine responsiveness of former Th2 cells was reprog-
rammed to a Th1 cell-like phenotype.
To determine the role of IL-12 and IFN-g signals in LCMV-
induced Th2 cell reprogramming, we adoptively transferred
virus-specific Thy1.1+ Th2 cells into WT, Il12b/, or Ifng/
recipients. Recipients were infected with LCMV, and some
groups were injected with anti-IFN-g during the course of infec-
tion to neutralize IFN-g that could potentially be produced by the
transferred Th2 cells. In all recipients, the progeny of the LCMV-
specific Th2 cells maintained a similar capacity to produce IL-4(data not shown). However, in the groups of mice where either
IL-12 or IFN-g signals were inhibited, induction of IFN-g was
impaired in the LCMV-specific Th2 cells (Figures 5C and 5D).
Strikingly, when LCMV-specific Th2 cells deficient in receptors
for either type I or type II interferons were transferred into
Thy1.1 congenic C57BL/6 mice, followed by LCMV infection of
the recipients, induction of IFN-g was almost abrogated in
both Th2 cell populations as well (Figure 5E). Thus, both type I
and type II interferon signals, acting directly on the LCMV-
specific Th2 cells, were essential for LCMV-induced Th2 cell
reprogramming.
Interferons and IL-12 Cooperate in Th2 Cell
Reprogramming In Vitro
Based on the observation in vivo that both type I and type II inter-
feron signals and IL-12 were required for LCMV-induced Th2 cell
reprogramming, we addressed the effect of these cytokinesImmunity 32, 116–128, January 29, 2010 ª2010 Elsevier Inc. 121
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Figure 5. Type I and Type II Interferons and IL-12 Are Essential for Virus-Induced Th2 Cell Reprogramming
(A–D) Naive WT LCMV-specific CD4+Thy1.1+ cells were differentiated to Th2 or Th1 cells for 2 weeks before transfer into naive C57BL/6, Il12b/, or Ifng/mice
as indicated.
(B–E) 14–30 days later, Th2 and Th1 cell recipients were infected with LCMV-WE.
(A and B) Cytokine-induced STAT4 and STAT1 phosphorylation and total STAT4 protein amounts in CD4+Thy1.1+ donor cells from spleen and lymph nodes were
determined on day 15 after transfer (A and B) and on day 13 after infection (B). Geometric mean indices ± SEM of pSTAT4 and pSTAT1 stainings of cytokine-
exposed versus untreated cells (A and B) and geometric mean indices ± SEM of total STAT4 stainings versus isotype control stainings (B) within CD4+Thy1.1+
donor cells are depicted (n = 5–6 mice per group and time point).
(C and D) After infection, some groups received neutralizing anti-IFN-g as indicated. 7 days after infection, IFN-g production of CD4+Thy1.1+ donor cells from
spleen and lymph nodes was measured upon restimulation with PMA plus ionomycin (n = 2–3 mice per group).
(E) Naive WT, Ifngr1/, and Ifnar1/ LCMV-specific CD4+Thy1.2+ cells were differentiated to Th2 cells for 2 weeks before transfer into naive Thy1.1 congenic
mice. Recipients were infected with LCMV-WE. 7 days later, IFN-g production of CD4+Thy1.2+ donor cells was measured upon restimulation of splenocytes
with PMA plus ionomycin (n = 2–3 mice per group).
Mean frequencies ± SEM of IFN-g+ cells within CD4+Thy1.1+ (C and D) or CD4+Thy1.2+ (E) donor cells are indicated. ns, not significant; *p < 0.05; **p < 0.01;
***p < 0.001.
Immunity
Interferons Direct Th2 Cell Reprogramming by T-betin vitro. Neither type I or type II interferon alone nor both types of
interferons together were able to induce substantial amounts of
IFN-g in Th2 cells (Figure 6A and data not shown). However,
a combination of type I and type II interferons plus IL-12
succeeded in inducing IFN-g production, and coexpression of122 Immunity 32, 116–128, January 29, 2010 ª2010 Elsevier Inc.IFN-g with Th2 cytokines in the same cell was stochastic.
When Th2 cells deficient in receptors for either type I or type II
interferons were exposed to a combination of both types of inter-
ferons plus IL-12, the induction of IFN-g was substantially
reduced compared with WT Th2 cells (Figure S5A). Thus, type I
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Figure 6. Interferons and IL-12 Cooperate in Th2 Cell Reprogramming In Vitro
(A) Naive WT LCMV-specific CD4+ T cells were differentiated to Th2 cells for 5 days. Th2 cells were reactivated under different polarizing conditions in the
presence of the indicated cytokines and cytokine antibodies for further 5 days. Data are representative of at least four independent experiments.
(B) Naive WT and Tbx21/ LCMV-specific CD4+ T cells were differentiated to Th2 cells for 5 days. Then Th2 cells were reactivated in the presence of IL-12, IFN-g,
IFN-a+b, and anti-IL-4 for further 5 days.
(A and B) On day 5 of the secondary stimulation, cells were reactivated with PMA plus ionomycin and stained for CD4 and intracellular cytokines. Percentages of
cytokine+ CD4+ cells are indicated.
Immunity
Interferons Direct Th2 Cell Reprogramming by T-betinterferon, type II interferon, and IL-12 each contributed essential
signals to Th2 cell reprogramming toward IFN-g production
in vitro.
Moreover, the combination of both types of interferons with
IL-12 also led to a similar GATA-3+T-bet+ phenotype in former
Th2 cells in vitro as it was generated in the course of the LCMV
infection. Production of IFN-g showed a positive correlation
with T-bet and a negative correlation with GATA-3 protein
amounts (Figure S5B). This treatment also reprogrammed Th2
cells to switch to a Th1 cell-like cytokine signaling phenotype
by gaining IL-12 responsiveness and losing IFN-g responsive-
ness (Figure S5C). In addition and again similar to the situation
in vivo (compare Figure 3E), both the induction of IFN-g produc-
tion as well as the activation and upregulation of STAT4 protein in
former Th2 cells in vitro entirely depended on the cells’ capacity
to express T-bet (Figure 6B; Figure S5D). In summary, both
in vitro and in vivo, type I and type II interferons together with
IL-12 could reprogram Th2 cells to adopt a GATA-3+T-bet+
Th2+1 phenotype with the capacity to coproduce Th2 and Th1
cytokines.
T-bet Induction in Adoptively Transferred Virus-Specific
Th2 Cells Is Crucial to Prevent LCMV Persistence
and Fatal Immunopathology
To assess the functional relevance of Th2 cell plasticity in vivo,
we adoptively transferred LCMV-specific WT Th1 or Th2 cells
or Tbx21/ Th2 cells into naive Thy1.1 congenic C57BL/6
mice and infected the recipients with a low dose (200 PFU) of
LCMV. Because LCMV is a noncytolytic virus, signs of infec-
tion-associated disease reflect virus-dependent immunopa-
thology (Zinkernagel et al., 1986). Mice that had received
LCMV-specific WT Th1 or Th2 cells showed a transient loss of
body weight that reached its maximum around day 7 (Figure 7A).
Th1 cell recipients were more severely affected than were Th2
cell recipients, which is in line with our previous observation of
reduced virus-induced immunopathology in Th2 versus Th1cell-recipient mice (Lo¨hning et al., 2008). Thereafter, all mice of
both groups rapidly recovered and returned to almost their start-
ing weight by day 14. In contrast, eight out of eight recipients of
Tbx21/ Th2 cells developed a fatal wasting syndrome with
constant and dramatic weight loss until day 12 without any signs
of recovery, such that a humane endpoint was reached, neces-
sitating termination of the experiment. Tbx21/ Th2 cells main-
tained their Th2 cytokine profile and, unlike WT Th2 cells, failed
to acquire IFN-g production (Figure 7B).
Strikingly, the endogenous CD8+ T cell response against
LCMV was severely impaired by the presence of Tbx21/, but
not WT, Th2 cells (Figures 7C–7E; Figure S6). Absolute numbers
of endogenous CD8+ T cells specific for and reactive to the
dominant LCMV glycoprotein and nucleoprotein epitopes,
GP33 and NP396, were several hundredfold lower in spleens
of Tbx21/ Th2 cell recipients when compared with recipients
of WT Th2 cells (Figures 7C and 7D; Figures S6A and S6B).
Also in nonlymphoid organs, recipients of Tbx21/ Th2 cells
showed a drastic reduction in the frequencies of GP33- or
NP396-specific CD8+ T cells (Figure 7E; Figure S6C). In line
with the defective LCMV-specific CD8+ T cell response, recipi-
ents of Tbx21/ Th2 cells, but not recipients of WT Th2 or Th1
cells or untreated mice, were unable to control even a low
dose of LCMV infection (Figure 7F). Virus propagated exces-
sively and persisted at very high titers in lymphoid and nonlym-
phoid organs. Thus, the presence of LCMV-specific Tbx21/
Th2 cells in otherwise untreated normal WT mice prevented an
effective endogenous antiviral response and resulted in the
conversion of a transient LCMV infection into a persistent form
accompanied by fatal immunopathology.
DISCUSSION
In this report, we have addressed the plasticity of Th2 cell
commitment and its functional relevance predominantly in vivo
by using adoptive cell transfers, viral infections, and single-cellImmunity 32, 116–128, January 29, 2010 ª2010 Elsevier Inc. 123
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Figure 7. T-bet Induction in Adoptively Transferred Virus-Specific Th2 Cells Is Crucial to Prevent LCMV Persistence and Fatal
Immunopathology
Naive WT and Tbx21/ LCMV-specific CD4+Thy1.2+ cells were differentiated to Th2 or Th1 cells for 2 weeks before transfer into naive untreated Thy1.1 congenic
mice. 7 days after transfer, recipient mice were challenged with 200 PFU LCMV-WE.
(A) Body weight (mean ± SEM) and survival were monitored daily (n = 7–8 mice per group). Starting day 6 after infection, differences in body weight between
Tbx21/ Th2 and WT Th2 cell recipients were significant (*p < 0.05; **p < 0.01; ***p < 0.001).
(B) 7 days after infection, cytokine production of CD4+Thy1.2+ donor cells was measured upon restimulation of splenocytes with PMA plus ionomycin
(n = 3 mice per group).
(C–E) Endogenous LCMV-specific CD8+ T cells were enumerated by MHC class I tetramers (H-2DbGP33 and H-2DbNP396) on day 12 after infection.
(C and D) Absolute numbers of GP33- and NP396-specific CD8+ T cells in spleen were determined (mean ± SEM, n = 2–4 mice per group).
(E) Frequencies of GP33-specific CD8+ T cells within total CD8+ T cells in various organs are shown (mean ± SEM, n = 2–4 mice per group).
(F) Virus titers in blood and various organs were measured by immunofocus assay on day 12 after infection (mean ± SEM, n = 2–4 mice per group). Data are
representative of two independent experiments.
Immunity
Interferons Direct Th2 Cell Reprogramming by T-betanalyses of key transcription factors, signal transduction mole-
cules, and cytokines. Several findings were obtained. First,
elevated protein expression of GATA-3 or T-bet was stably
maintained in resting Th2 or Th1 cells for months without antigen124 Immunity 32, 116–128, January 29, 2010 ª2010 Elsevier Inc.challenge. This stability at the level of key transcription factors
correlated with the stable maintenance of the functional pheno-
type of Th2 or Th1 memory cells in terms of cytokine profiles and
cytokine signaling capacity. Second, the lineage commitment of
Immunity
Interferons Direct Th2 Cell Reprogramming by T-betGATA-3+ Th2 cells was plastic and could be reprogrammed by
TCR triggering in the context of an LCMV infection in vivo as
well as by a combination of type I and type II interferons plus
IL-12 in vitro. Third, both in vivo and in vitro, Th2 cell lineage
reprogramming was entirely dependent on T-bet and resulted
in cells coexpressing GATA-3 and T-bet as well as Th2 and
Th1 cytokines. Fourth, the GATA-3+T-bet+ and IL-4+IFN-g+
Th2+1 phenotype was stably maintained in vivo for months, sug-
gesting lineage-like properties. And finally, T-bet-dependent
reprogramming of adoptively transferred LCMV-specific Th2
cells was crucial in vivo to establish a protective antiviral
response and to prevent fatal immunopathology upon LCMV
infection.
The plasticity of T cell differentiation programs has been a
matter of intense research for many years, and particularly Th2
cells having undergone several cell divisions were reported to
be stably committed and resistant to Th1 cell-favoring manipula-
tions (Grogan et al., 2001; Hu-Li et al., 1997; Messi et al., 2003;
Murphy et al., 1996; Perez et al., 1995; Szabo et al., 1995).
Here, we provide evidence that a combination of innate and
adaptive immune signals with key functions in antiviral immune
responses can reprogram Th2 cell commitment and induce
GATA-3+ Th2 cells to acquire additional expression of T-bet
and Th1 cytokines. The partially flexible behavior of the Th2
cell lineage is in line with a recent study showing a bivalent, non-
silenced epigenetic state of the Tbx21 gene in Th2 cells (Wei
et al., 2009). Thus our results demonstrate the plasticity of the
Th2 cell lineage decision, because GATA-3 and T-bet can be
expressed quite independently of one another in single cells
and, in turn, mediate the execution of their respective down-
stream Th2 and Th1 cytokine programs.
In the course of Th2 cell lineage differentiation, molecular
changes take place that apparently narrow the responsiveness
of Th2 cells to reprogramming toward Th1 cells. In agreement
with previous reports (Ouyang et al., 1998; Szabo et al., 1995,
1997; Usui et al., 2003), we observed that Th2, but not Th1, cells
lost the capacity to respond to IL-12 signals with phosphoryla-
tion of STAT molecules, and also the total amount of STAT4
protein per Th2 cell was reduced. However, the capacity to
signal in response to IFN-a+b and IFN-g was still maintained
by Th2 cells, and treatment with a combination of IFN-a+b and
IFN-g even had additive effects. Remarkably, LCMV-induced
Th2 cell reprogramming required both IFN-aR and IFN-gR
signaling directly in virus-specific Th2 cells, whereas expression
of these receptors on APCs or other cell types was not sufficient.
Cooperative interactions of IFN-aR1 with IFN-gR2 have been
described, leading to efficient STAT1 activation upon IFN-g
stimulation (Takaoka et al., 2000). In addition, in CD8+ and Th1
cells, but not in naive CD4+ T cells, IFN-a, although less potent
than IL-12, was shown to phosphorylate STAT4, which then
could bind to the Ifng gene and transiently enhance IFN-g
production (Berenson et al., 2006; Nguyen et al., 2002). We
here extend this observation to Th2 cells, phosphorylating
STAT4 and STAT1 in response to IFN-a+b. Interestingly, IFN-a
was reported to induce transient, but not sustained, T-bet
expression in naive human CD4+ T cells, whereas stable expres-
sion of T-bet and Th1 cell differentiation were achieved by IL-12
(Ramos et al., 2007). Moreover, a concerted action of activated
STAT4 and T-bet appears critical for the induction of IL-12Rb2and IFN-g memory expression (Afkarian et al., 2002; Mullen
et al., 2001; Thieu et al., 2008). Thus, in conjunction with these
findings, our observations in the context of a viral infection
may suggest cooperative signaling of virus-induced type I and
type II interferons to act as a ‘‘door opener’’ in Th2 cells. By elic-
iting transient phosphorylation of the reduced, but not deficient,
number of STAT4 molecules in parallel with additive effects on
STAT1 activation, transient induction of IFN-g and T-bet could
be envisaged (Afkarian et al., 2002; Ramos et al., 2007). T-bet
has the potential to directly interact with GATA-3 and inhibit
its binding to DNA (Hwang et al., 2005). This may relieve
GATA-3’s repression of Il12rb2 and Stat4 expression (Ouyang
et al., 1998; Usui et al., 2003), allowing regain of IL-12 respon-
siveness via activated STAT4 (Usui et al., 2006). Elevated
amounts of activated STAT4 could then stably imprint the
Tbx21 and Ifng genes for memory expression (Schulz et al.,
2009). Of note, this is a speculative scenario, and the exact
sequence of events during the reprogramming of Th2 cells
remains to be determined by future experimentation. In addition,
the process of Th2 cell reprogramming in the course of a viral
infection required not only a proinflammatory, IFN-rich environ-
ment but also concomitant TCR triggering by cognate antigen.
In functional terms, LCMV-triggered T-bet induction in adop-
tively transferred virus-specific Th2 cells was essential to estab-
lish a protective antiviral response, preventing viral persistence
and fatal immunopathology. If coexpressed with Th1 cytokines,
Th2 cytokines may have beneficial effects, resulting in efficient,
protective T cell responses in conjunction with reduced immuno-
pathology in Th2 versus Th1 cell-recipient mice (Lo¨hning et al.,
2008). Yet, if virus-specific Th2 cells fail to acquire additional
production of T-bet and Th1 cytokines, we here found the
endogenous antiviral immune response to be rendered dysfunc-
tional and no longer protective. Thus, the plasticity of Th2 cell
lineage commitment allowing balanced coproduction of Th2
and Th1 cytokines can be of fundamental importance to cope
with differential requirements for optimized immune responses,
and an irreversibly imprinted differentiation program excluding
the acquisition of further functional competences may lead to a
fatal misdirection of the response to a pathogen. Some cytokines
that can be secreted by Th2 cells, such as IL-4 or IL-10, have the
potential to limit the stimulatory capacity of antigen-presenting
dendritic cells (Brooks et al., 2006; Ejrnaes et al., 2006; King
et al., 2001). This may have led to the impaired activation of
endogenous LCMV-specific CD8+ T cells that are required to
control LCMV infections (Zinkernagel et al., 1986). However,
other mechanisms counteracting IFN- and TNF-driven inflam-
matory and antiviral processes, such as direct cytokine effects
on CD8+ T cells and other cell types, could also be envisaged
and will be addressed in future work.
In adoptively transferred Th2 or Th1 cells resting in normal,
naive mice, elevated protein expression of GATA-3 or T-bet was
maintained in a stable and constitutive manner for >70 days.
During the whole time period, both key transcription factors
showed a homogeneous expression pattern in all cells of the
T cell population without indication for larger fluctuations or
subpopulations. Long-term stabilization of enhanced GATA-3
or T-bet protein expression in single memory cells in vivo may
have been achieved by self-amplifying autoactivation and/or
cell-intrinsic positive feedback loops that were demonstratedImmunity 32, 116–128, January 29, 2010 ª2010 Elsevier Inc. 125
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Interferons Direct Th2 Cell Reprogramming by T-betto be active in the regulation of Gata3 or Tbx21 gene expression
in effector populations in vitro (Afkarian et al., 2002; Mariani et al.,
2004; Mullen et al., 2001; Ouyang et al., 2000). Remarkably, in
the T-bet-dependent reprogramming process of Th2 cells,
production of GATA-3 protein was still maintained, resulting in
Th2+1 cells stably coexpressing GATA-3 and T-bet for months.
Intermediate plateau expression of both key transcription factors
was established between the amounts of GATA-3 and T-bet
proteins in ‘‘classical’’ Th2 or Th1 memory cells. Moreover, the
cells also maintained their original capacity to produce the Th2
cytokines IL-4 and IL-13, while additional competence for
IFN-g production was acquired. The long-term maintenance of
the GATA-3+T-bet+ and IL-4+IFN-g+ Th2+1 phenotype in vivo
suggests lineage-like properties of these cells. Of note, the
virus-induced Th2 cell reprogramming preserving GATA-3 and
IL-4 production is qualitatively different from the recently
reported TGF-b-induced reprogramming of Th2 cells into an
IL-9- and IL-10-secreting ‘‘Th9’’ phenotype, which was charac-
terized by a loss of GATA-3 and IL-4 expression (Veldhoen
et al., 2008). Rather, our finding is in line with a continuous role
of GATA-3 in the maintenance of efficient Th2 cytokine memory
including expression of the Il13 gene, which is directly regulated
by GATA-3 (Kishikawa et al., 2001; Pai et al., 2004; Yamashita
et al., 2002, 2004; Zhu et al., 2004). Thus, a plastic process of
sequential acquisition of key transcription factor expression
and their downstream differentiation programs without extin-
guishing the previously acquired differentiation memory may
contribute numerous additional facets to canonical T cell differ-
entiation subsets. The long-term balanced coexistence of Th2
and Th1 cell differentiation programs in single GATA-3+T-bet+
memory T cells may provide a molecular mechanism for more
flexible, highly individualized, and optimally adapted immune
responses to a plethora of invading pathogens by adjusting
a fine balance between protective and immunopathological
inflammatory processes.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6J and C57BL/6J mice congenic for Thy1.1 (B6.PL-Thy1a/CyJ) were
bred under specific pathogen-free conditions at the Charite´, Berlin, or at the
University of Zurich, and were used as recipients for adoptive cell transfers
at the age of 8–12 weeks. Ifnar1/ mice, Ifngr1/ mice, Ifng/ mice,
Il12b/mice, Tbx21/mice, and SMARTA1 TCR-transgenic (tg) mice, which
express a TCR specific for the LCMV epitope GP61–80, were all on C57BL/6J
background (for details, see Supplemental Experimental Procedures). All
animal experiments were performed in accordance with the German and
Swiss law for animal protection with permission from the local veterinary
offices.
Viruses
LCMV variant, LCMV-WEDGP61-68 (Recher et al., 2004), carrying an 8 amino
acid deletion at positions 61–68 of the LCMV glycoprotein, and WT LCMV-
WE strains were propagated on L929 cells. LCMV virus stocks and organ
samples were titrated by standard immunofocus assays on MC57G cells as
described previously (Recher et al., 2004). Mice were infected intravenously
with 200 plaque-forming units (PFU) in 200 ml.
T Cell Activation and Differentiation
Naive MACS-sorted LCMV-TCRtg CD4+CD62LhiCD25 T cells from spleens
and lymph nodes were cultured as described previously (Lo¨hning et al.,
2008). For details, see Supplemental Experimental Procedures.126 Immunity 32, 116–128, January 29, 2010 ª2010 Elsevier Inc.Flow Cytometry and Cell Sorting
Lymphocytes were isolated from peripheral blood, spleens, and lymph nodes
and were stained as described previously (Lo¨hning et al., 2008). Antibody
clones and intracellular detection of cytokines, key transcription factors, and
STAT proteins are described in Supplemental Experimental Procedures.
Cytokine Analysis in Serum
The concentrations of IFN-a, IL-12p70, and IFN-g in sera were determined
with IFN-a ELISA (PBL Biomedical Laboratories) or Cytometric Bead Arrays
(BD Biosciences) according to the manufacturer’s instructions.
Statistical Analysis
Two groups were compared with two-tailed unpaired Student’s t test. More
than two groups were compared via one-way ANOVA with Bonferroni’s post
test for multiple comparisons. Time courses of multiple groups were compared
with two-way ANOVA.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at doi:10.1016/
j.immuni.2009.12.004.
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